Aben Resources Closes $950,000 Flow-Through Private Placement

Aben Resources Ltd. (TSX-V: ABN) (OTCQB: ABNAF) (Frankfurt: E2L2) (the “Company”) has arranged and closed a non-brokered private placement of 2,375,000 flow-through common shares at a price of $0.40 each for gross proceeds of $950,000. The financing was placed with institutional investors. The Company intends to utilize the proceeds from the private placement on the expansion of its 2018 exploration and drilling program at its Forrest Kerr Gold Project located in the Golden Triangle region of British Columbia. The Company had originally announced and budgeted for up to 5000 metres of drilling and now intends to at least double that amount this year. read more

FSD Pharma Issues 40,000,000 Stock Options to Director Dr. Raza Bokhari Conditional on NASDAQ listing

C.HUGE, FSD Pharma, cannabis, pot
Cision

FSD Pharma Inc. (“FSD Pharma” or the “Company”) (CSE: HUGE) (OTC: FSDDF) (FRA: 0K9) announces that pursuant to its Stock Option Plan, the Board approved the grant of 3,000,000 stock options for class B subordinate voting shares of the Company (the “Options“) on August 14, 2018 to Dr. Raza Bokhari following his appointment as a Director. The Options vest immediately and are exercisable at a price of $0.13 for a period of five years. The Company has also cancelled 15,000,000 stock options that had been previously issued at $0.05 read more